Company intelligence / Profile preview

SWAN Venture Fund II

Mercer Island, Washington, United States

Ownership: Private
Development stage: Other

Overview

SWAN Venture Fund II is a 2018-vintage early-stage venture and angel investment fund managed by SWAN Venture Fund. The fund is part of a Pacific Northwest-focused investment platform that backs pre-seed and seed-stage companies across sectors including healthcare, diagnostics, and health information technology. Rather than operating as a drug-development company, SWAN Venture Fund II functions as an investment vehicle that provides capital and support to startups. Available public information indicates the fund has participated in healthcare-related financings, including medtech and diagnostics opportunities in the Seattle and broader Northwest ecosystem.

Industry: Investors

Beyond the preview

Go deeper on SWAN Venture Fund II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SWAN Venture Fund II.

Explore the full profile